The R21/Matrix-M\u2122\u202fmalaria vaccine, developed by the Jenner Institute, and manufactured by the Serum Institute of India which leverages Novavax\u2019s adjuvant technology, has been licensed for use in Burkina Faso by the country\u2019s regulatory agency, Agence Nationale de la Regulation Pharmaceutique.
A delegation from the Ministry of Education (MoE) of the People's Republic of China visited the University of Oxford and was hosted at the Nuffield Department of Medicine (NDM) by Professor Tao Dong, Ita Askonas Professor of Translational Immunology and Director of the Chinese Academy of Medical Sciences Oxford Institute (COI).
NDM\u2019s Infectious Diseases Data Observatory and its global collaborators have developed new case report forms providing researchers with a standardised means of recording any data on visceral leishmaniasis, allowing them to compare studies and relate data to the efficacy of visceral leishmaniasis treatments from different groups of researchers.
While 17 countries have now achieved trachoma elimination status, there is still work to be done, with trachoma responsible for the blindness or visual impairment of about 1.9 million people worldwide. Collaborators are being invited to join a new research project aimed at assessing the drivers for persistent and recrudescent trachoma.
The annual conference of the Chinese Academy of Medical Sciences Oxford Institute took place in Chengdu, in the Sichuan province of China between 1-3 June 2023.
Professor Sir John Irving Bell, Regius Professor of Medicine at the University of Oxford and former Head of Department of the Nuffield Department of Medicine, has been appointed a Companion of Honour in the King\u2019s Birthday Honours list. He was knighted in 2015 for services to medicine, medical research and the life science industry.
In order to support the Nuffield Department of Medicine in seeking out new opportunities for innovation and delivering impact across its 24 units, Prof Richard Cornall, the Head of Department, has appointed Prof Bountra in a new role within NDM Strategic.
Professor Sir Peter Horby, Director of NDM's Pandemic Sciences Institute, today advised a committee at the UK Houses of Parliament of the importance of strategic scientific research funding to prepare the UK for a future pandemic, alongside Professor Bryan Charleston, Director and CEO of The Pirbright Institute.
Within weeks of the pandemic starting, the Nuffield Department of Medicine (NDM) began antibody testing as part of the UK\u2019s ONS COVID-19 Infection Survey. The platform successfully tested millions of blood samples over three years, providing invaluable information on how vaccinations and previous infections affect the chance of getting COVID-19 again.
Researchers at the Kemri Wellcome Trust in collaboration with colleagues from various modelling groups and the World Health Organization have designed a framework to guide the use of mathematical modelling in evidence-based policy decision making.
1000 patients were successfully recruited by the Prospective Cohort for Early Detection of Liver Cancer (Pearl) clinical study. This study has been developed to recruit patients with cirrhosis who are known to be at high risk for liver cancer.
NDM\u2019s OUCRU and partners have been developing a training programme to enhance the capacity of local health workers in Viet Nam, who are often low-paid volunteers with little training. Communes that participated in the training programme saw up to a 42% increase in booster vaccination uptake compared to the communes that did not participate.
We are delighted to announce that six researchers have been awarded the Associate Professor title, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.
Professor Cecilia Lindgren from the Big Data Institute and Professor Yang Shi from the Oxford Branch of the Ludwig Institute for Cancer Research have been elected as Fellows of the Academy of Medical Sciences.
We regret to announce the passing of Professor Dominic Kwiatkowski, Professor of Tropical Paediatrics at the Nuffield Department of Medicine, and a renowned researcher who dedicated his life to the research on malaria. Prof Kwiatkowski passed away in April 2023 at the age of 69.
The multi-partner COVID Moonshot consortium was a runner-up in the Innovation Enabled by Partnership category, which recognises and celebrates scientific innovation that has been enabled as a direct result of collaborative partnerships.
A team including NDM researchers aims to co-create equitable and sustainable solutions to manage antimicrobial resistance, using a conceptual framework developed by the International Labour Organisation to guide climate action.
Eight academics from the University of Oxford have been selected to join the Royal Society as Fellows, including Prof Gilbert from the Pandemic Sciences Institute. The fellows have been selected for their substantial contribution to the advancement of science.
Professor James H Naismith will be the new Head of Oxford\u2019s Mathematical, Physical and Life Sciences Division, taking over from Prof Sam Howison in October 2023.
Eric and Wendy Schmidt have announced the members of the 2023 cohort of Schmidt Science Fellows, including T. Bertie Ansell, a researcher at NDM's Division of Structural Biology. The 32 exceptional early career scientists will receive support to develop research projects and the leadership skills necessary to harness interdisciplinary science to tackle some of the world\u2019s most intractable problems.
![\"\"](\"https://www.ndm.ox.ac.uk/news/r21-matrix-mtm-malaria-vaccine-cleared-for-use-in-burkina-faso/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n